Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - July 7, 2025 Deadline to Join – Contact Levi & Korsinsky — Neutral
WST GlobeNewsWire — May 30, 2025NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.
MicroStrategy Rises 28% Year to Date: Buy, Sell or Hold the Stock? — Neutral
MSTR Zacks Investment Research — May 30, 2025MSTR is up 27.9% year to date, fueled by bitcoin gains and rising subscriptions, but a premium valuation makes the stock risky.
Ongoing Securities Investigation into UroGen Pharma Ltd. (URGN) - Contact Levi & Korsinsky — Neutral
URGN Accesswire — May 30, 2025NEW YORK, NY / ACCESS Newswire / May 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of UroGen Pharma Ltd. ("UroGen Pharma Ltd.
PLEASANTON, Calif. , May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Baird 2025 Global Consumer, Technology & Services Conference, New York, NY.
CODI ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Compass Group Diversified Holdings, LLC - July 8, 2025 Deadline — Neutral
CODI Accesswire — May 30, 2025NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151021&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by July 22, 2025 to Join Class Action Against Organon & Co. (OGN) — Neutral
OGN Accesswire — May 30, 2025NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151019&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Compass Diversified Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Firm - CODI — Neutral
CODI Accesswire — May 30, 2025NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / WHY: New York, N.Y., May 30, 2025.
Canopy Growth shares slide after wider loss, lower revenue in Q4 — Negative
CGC Proactive Investors — May 30, 2025Shares of Canopy Growth Corporation (TSX:WEED, NYSE:CGC) tumbled on Friday after the Canadian cannabis producer reported a wider quarterly loss and a decline in revenue, as it continues to grapple with ongoing operational and market challenges. The stock fell over 21% in New York and more than 19% in Toronto following the company's fiscal fourth-quarter results.
Marvell: When The Market Thinks Good Earnings Still Aren't Good Enough — Negative
MRVL Seeking Alpha — May 30, 2025Marvell Technology delivered strong FQ1 results, driven by 76% YoY data center revenue growth, but near-term growth may have peaked. Revenue concentration in Amazon and the delayed Microsoft ramp create execution risks, especially as AI CapEx plans face uncertainty. Valuation has normalized, offering an attractive risk/reward for long-term investors despite the potential for sideways price action.
With the April sell-off in the rearview mirror, investors may want to start looking at SMIDcap opportunities again to capture value-tilted upside. That's because their large-cap counterparts have recovered.
Gilead Sciences Stock Gains 21% YTD: Buy, Sell or Hold? — Positive
GILD Zacks Investment Research — May 30, 2025GILD stock jumps 21.1% YTD as HIV dominance, lenacapavir progress, and liver drug approval offset oncology pressures. However, we recommend investors remain on the sidelines at current levels.
Bath & Body Works Q1 Earnings Beat Estimates, Sales Rise Y/Y — Positive
BBWI Zacks Investment Research — May 30, 2025BBWI reports higher earnings and sales in the fiscal first quarter, boosted by product innovation and strong supply-chain performance.
Transaction in Own Shares 30 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 30 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 30/05/2025 536,589 £24.7250 £24.4300 £24.5634 LSE GBP 30/05/2025 190,255 £24.7200 £24.4300 £24.5692 Chi-X (CXE) GBP 30/05/2025 111,156 £24.7200 £24.4550 £24.5842 BATS (BXE) GBP 30/05/2025 446,721 €29.5650 €29.2100 …
3 Defense Stocks That Will Profit From a Golden Dome — Positive
LHX LMT PLTR MarketBeat — May 30, 2025As one part of his “Make America Great Again” agenda, President Donald Trump is proposing the construction of a “Golden Dome” defense system. This comprehensive, mobile air defense system will be similar to the Golden Dome that protects Israel.
Braskem: A New Shareholder Specializing In Turnarounds Could Be The Trigger — Positive
BAK Seeking Alpha — May 30, 2025Braskem is a leading Brazilian petrochemical company specializing in resins like polyethylene, polypropylene, and PVC. Investor Nelson Tanure, known for corporate restructuring, has made a surprise purchase offer for Braskem. The announcement of Tanure's offer led to a sharp 9% increase in Braskem's share price, reflecting strong market interest.
Nvidia posted strong first quarter results but investors might be missing a critical part of the story. Transcript: ANGELO ZINO: So the biggest takeaways from NVIDIA and our outlook on the stock, I'd say the biggest takeaway for NVIDIA on the April quarter has to be on the guidance side.
Pension funds that own $2.8 billion of Tesla's stock slam board for failing to rein in Musk — Negative
TSLA Market Watch — May 30, 2025As Elon Musk steps away from DOGE, Tesla faces a long-overdue stockholder “intervention.”
Palantir Technologies Inc (NASDAQ:PLTR) is one of the best stocks on the Nasdaq today, last seen up 6.4% to trade at $130.17.
Regeneron shares plunge after mixed COPD drug trial results — Negative
REGN Proactive Investors — May 30, 2025Shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) sank nearly 19% on Friday after the company's experimental COPD drug, developed with partner Sanofi SA (ADR) (NYSE:SNY), posted mixed results in two Phase 3 trials—casting doubt on its regulatory path and delaying hopes for a major new revenue stream. The drug, itepekimab, reduced moderate or severe flare-ups by 27% compared to placebo over 52 weeks in the AERIFY-1 study, which enrolled 1,127 former smokers with chronic obstructive pulmonary disease (COPD).
Kohl's Q1 Loss Narrower Than Estimates, Sales Decline 4% Y/Y — Negative
KSS Zacks Investment Research — May 30, 2025KSS's fiscal first-quarter results reflect a net sales dip of 4.1% and a comparable sales decline of 3.9%. Management maintains fiscal 2025 guidance.
